Assessment and prevention of cardiovascular disease

Abstract

Identification and appropriate intervention for people at increased CVD risk will help to improve their chances of living longer, healthier lives and reduce the burden of CVD on the healthcare system. There are many opportunities in everyday practice for pharmacy teams to make a significant contribution to this important public health goal. Lifestyle modification is essential, but identification of people that would benefit from medication for primary or secondary prevention is also needed. Statins are the first-line medication, but an increasing number of other therapies are now available to use in addition or as alternatives to stain therapy. To maximise the benefits primary and secondary prevention measures, ongoing support for adherence to lifestyle and pharmacological treatments is vital.